Teriparatide Plus Zoledronic Acid for Osteogenesis Imperfecta: A Randomized Clinical Trial.
Hald JD, Weir CJ, Keerie C, Dewar L, MacLean M, Milne L, Keen R, Walsh JS, Poole KES, Langdahl BL, Lindsay JR, Ghouri N, Hollick R, Aspray T, Crowley RK, Cohen-Solal M, Hassan-Smith Z, Tuck S, Curtis EM, Harvey NC, Eekhoff EMW, Feenstra J, Hampson G, Stone M, Turton J, Patel P, Siddiqi M, Munro R, Roy M, Paskins Z, Narayanan D, Malcolm E, Javaid MK, Osborne P, Tang JCY, Lam W, Moore D, Black HA, Duckworth AD, Makaram NS, Guo T, Stenhouse G, Ralston SH; TOPaZ Investigators.
Hald JD, et al. Among authors: stone m.
JAMA. 2026 May 14:e266889. doi: 10.1001/jama.2026.6889. Online ahead of print.
JAMA. 2026.
PMID: 42133304